Increased GDP→GTP nucleotide exchange by RAC1-GEF in the context of the event of the activation of RAC1 mediates oncogenic effects, while alterations in RAC1-GAPs are not generally cancer associated [47,60]. This evidence concerns the gene RAC1 and cancer.